Literature DB >> 21978347

Cystic fibrosis in Australia, 2009: results from a data registry.

Scott C Bell1, Peter T P Bye, Peter J Cooper, A James Martin, Karen O McKay, Phillip J Robinson, Gerard F Ryan, Geoff C Sims.   

Abstract

OBJECTIVES: To describe the demographics, clinical features and outcomes among people with cystic fibrosis (CF) in Australia and to estimate incidence of the disease. DESIGN AND
SETTING: Cross-sectional analysis using data from the Australian Cystic Fibrosis Data Registry for 2009. MAIN OUTCOME MEASURES: Numbers of diagnoses, pulmonary and anthropometric measurements, microbiological culture results, rates of hospitalisation and transplantation, and numbers of medical complications and deaths.
RESULTS: In 2009, data were submitted on 2986 people (48% female). Median age was 17.6 years and 49% of people were aged 18 years or over. Seventy-eight people were newly diagnosed. Fourteen people died and 14 people underwent lung transplantation in the year. Lung function and nutrition were relatively normal among children but deteriorated (more rapidly) among adolescents. With increasing age, progressive respiratory disease was apparent, and the frequency of CF-related complications and use of health care resources increased. In all age groups, there was a wide range in severity of lung disease and nutritional status.
CONCLUSIONS: CF remains a progressive respiratory disease and is associated with multisystem complications. The acceleration in disease severity in adolescence and early adulthood suggests that better treatment at these stages is required to further improve survival.

Entities:  

Mesh:

Year:  2011        PMID: 21978347     DOI: 10.5694/mja11.10719

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  13 in total

Review 1.  Efficacy of screening immune system function in at-risk newborns.

Authors:  Christopher J Pavlovski
Journal:  Australas Med J       Date:  2014-07-31

Review 2.  Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines.

Authors:  Kathleen J Ramos; Patrick J Smith; Edward F McKone; Joseph M Pilewski; Amy Lucy; Sarah E Hempstead; Erin Tallarico; Albert Faro; Daniel B Rosenbluth; Alice L Gray; Jordan M Dunitz
Journal:  J Cyst Fibros       Date:  2019-03-27       Impact factor: 5.482

3.  Automated medical literature retrieval.

Authors:  Krumpholz Alexander; David Hawking; Richard Jones; Tom Gedeon; Hugh Greville
Journal:  Australas Med J       Date:  2012-09-30

4.  Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis.

Authors:  Kay A Ramsay; Claire A Butler; Stuart Paynter; Robert S Ware; Timothy J Kidd; Claire E Wainwright; Scott C Bell
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

5.  Ivacaftor in severe cystic fibrosis lung disease and a G551D mutation.

Authors:  Michelle E Wood; Daniel J Smith; David W Reid; Philip J Masel; Megan W France; Scott C Bell
Journal:  Respirol Case Rep       Date:  2013-10-10

6.  Methicillin-resistant Staphylococcus aureus acquisition in healthcare workers with cystic fibrosis: a retrospective cross-sectional study.

Authors:  Michelle E Wood; Laura J Sherrard; Kay A Ramsay; Stephanie T Yerkovich; David W Reid; Timothy J Kidd; Scott C Bell
Journal:  BMC Pulm Med       Date:  2016-05-11       Impact factor: 3.317

7.  Acceptability of patient reported outcome measures (PROMs) in a cystic fibrosis data registry.

Authors:  Irushi Ratnayake; Susannah Ahern; Rasa Ruseckaite
Journal:  BMJ Open Respir Res       Date:  2021-07

8.  Diabetes in cystic fibrosis: multicenter screening results based on current guidelines.

Authors:  Nicole Scheuing; Reinhard W Holl; Gerd Dockter; Katharina Fink; Sibylle Junge; Lutz Naehrlich; Christina Smaczny; Doris Staab; Gabriela Thalhammer; Silke van Koningsbruggen-Rietschel; Manfred Ballmann
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

9.  Respiratory exacerbation in a young adult with cystic fibrosis and tricuspid atresia.

Authors:  Jamie Wood; Abbey Sawyer; Siobhain Mulrennan; Andrew Bullock
Journal:  Respirol Case Rep       Date:  2018-04-01

10.  Effects of high intensity interval training on exercise capacity in people with cystic fibrosis: study protocol for a randomised controlled trial.

Authors:  Abbey Sawyer; Vinicius Cavalheri; Sue Jenkins; Jamie Wood; Nola Cecins; Bhajan Singh; Kylie Hill
Journal:  BMC Sports Sci Med Rehabil       Date:  2018-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.